Epidermal growth factor receptor (EGFR)-mutated lung cancer occurs in 15–20% of patients with adenocarcinoma and is most commonly associated with nonsmokers and those of Asian ethnicity. This evidence concerns the gene EGFR and adenocarcinoma.